Reduction in Risk Across Fourteen Obesity-Related Cancers A large observational study presented at the American Society of Clinical Oncology (ASCO) Annual Meeting 2025, involving more than 170,000 patients with diabetes and obesity, found that GLP-1 receptor agonists were associated with a modest but statistically meaningful reduction in the incidence of 14 obesity-related cancers , with colorectal cancer demonstrating particularly favourable outcomes when compared to patients receiving DPP-4 inhibitors
Use is restricted to qualified professionals operating in certified laboratory settings
This comprehensive quality assurance program, backed by HALAL, KOSHER, cGMP, FSSC22000, ISO9001, and ISO22000 certifications, provides the confidence required for regulatory submissions and commercial production of peptide-based therapeutics
Bacteriostatic Water (3 mL) Research Solution
Nature (1977) 266(5597):602
Licensed clinicians can prescribe it through compounded pharmacies where permitted